Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae (12/14/2017)
view
Amarantus BioScience Holdings Inc.
(AMBS:OTCQB)
Amarantus Subsidiary MANF Therapeutics Announces Publication in Science Magazine of Positive Animal Data for MANF in Treatment of Retinal Damage and Issuance of Retinal Patent in Japan Covering MANF and CDNF (12/14/2017)
view
Resverlogix Corp.
(RVX:TSX)
Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders (12/12/2017)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Announces NDA Acceptance of Indivior's RBP-7000 Risperidone Monthly Depot (12/13/2017)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
Wired News - Medigene Announced Collaboration with RXi Pharma to Further Improve its Therapeutic T Cells (12/13/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Juno Reports Additional Data on CAR-T Therapy, Shares Drop (12/12/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Forecasts 2018 Revenue To Be In The Range Of $383 Million To $387 Million (12/13/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Announces Release Of 2018 Guidance And Shareholder Conference Call (12/12/2017)
view